<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Fertil Steril</journal-id><journal-id journal-id-type="iso-abbrev">Int J Fertil Steril</journal-id><journal-id journal-id-type="publisher-id">Royan Institute</journal-id><journal-title-group><journal-title>International Journal of Fertility &#x00026; Sterility</journal-title></journal-title-group><issn pub-type="ppub">2008-076X</issn><issn pub-type="epub">2008-0778</issn><publisher><publisher-name>Royan Institute</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">24520458</article-id><article-id pub-id-type="pmc">3850330</article-id><article-id pub-id-type="other">Int-J-Fertil-Steril-7-13</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject><subj-group><subject>Gynecology and Female Infertility</subject><subject>Embryology</subject></subj-group></subj-group></article-categories><title-group><article-title>Effect of Progesterone Supplementation on Natural
Frozen-Thawed Embryo Transfer Cycles: A Randomized
Controlled Trial</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Eftekhar</surname><given-names>Maryam</given-names></name><degrees>M.D.</degrees><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Rahsepar</surname><given-names>Mozhgan</given-names></name><degrees>M.D.</degrees><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Rahmani</surname><given-names>Elham</given-names></name><degrees>M.D.</degrees><xref ref-type="aff" rid="A2">2</xref><xref ref-type="corresp" rid="cor1">*</xref></contrib><aff id="A1"><label>1</label>Yazd Research and Clinical Center for Infertility, Shahid Sadoughi University of Medical Sciences, Yazd, Iran</aff><aff id="A2"><label>2</label>Department of Obstetrics and Gynecology, Faculty of Medicine, Bushehr University of Medical
Sciences, Bushehr, Iran</aff></contrib-group><author-notes><corresp id="cor1">
* Corresponding Address:
<addr-line>P.O.Box: Box: 3631</addr-line><addr-line>Department of Obstetrics and Gynecology</addr-line><addr-line>Faculty of Medicine</addr-line><institution>Bushehr University
of Medical Sciences</institution><addr-line>Bushehr</addr-line><country>Iran</country>
Email: <email>Rahmani@bpums.ac.ir</email></corresp></author-notes><pub-date pub-type="ppub"><season>Apr-Jun</season><year>2013</year></pub-date><pub-date pub-type="epub"><day>6</day><month>3</month><year>2013</year></pub-date><volume>7</volume><issue>1</issue><fpage>13</fpage><lpage>20</lpage><history><date date-type="received"><day>30</day><month>4</month><year>2012</year></date><date date-type="accepted"><day>1</day><month>10</month><year>2012</year></date></history><permissions><copyright-statement>Any use, distribution, reproduction or abstract of this publication in any medium, with the exception of commercial purposes, is permitted provided the original work is properly cited</copyright-statement><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.5/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title>Background:</title><p>The transfer of cryopreserved embryos can be timed with ovulation in a
natural cycle or after artificially preparing the endometrium with exogenous hormones.
Progesterone is essential for the secretory transformation of the endometrium that permits
implantation as well as maintenance of early pregnancy. The purpose of this study
is to assess the effect of luteal phase supplementation on pregnancy rates in natural
frozen-thawed cycles.</p></sec><sec><title>Materials and Methods:</title><p>The study was designed as a prospective randomized clinical
trial of 102 women who underwent embryo transfers in natural cycles. The women in the
interventional group (n=51) received intra muscular (IM) progesterone 50 mg twice a day
starting from 36 hours after hCG administration. The control group (n=51) did not receive
any progesterone support.</p></sec><sec><title>Results:</title><p>There were no significant differences in demographic characteristics between
the groups and no statistically significant differences were observed between study and
control groups in clinical pregnancy rate (33.3% vs. 27.5%, p=0.66). There were no differences
in implantation rate or spontaneous abortion rate.</p></sec><sec><title>Conclusion:</title><p>Our results suggest that luteal phase support does not affect clinical pregnancy
rates in natural frozen-thawed embryo transfer cycles (Registration Number:
IRCT201108044339N6).</p></sec></abstract><kwd-group><kwd>Progesterone</kwd><kwd>Pregnancy Rate</kwd><kwd>Embryo Transfer</kwd><kwd>Natural Cycle</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>Citation</meta-name><meta-value>Eftekhar M, Rahsepar M, Rahmani E. Effect of progesterone supplementation on natural frozenthawed
Embryo transfer cycles: a randomized controlled trial. Int J Fertil Steril. 2013; 7(1): 13-20.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec><title>Introduction</title><p>Cryopreserved-thawed embryo transfer began
in 1983 and became a popular, vital component of
assisted reproduction technology (<xref rid="B1" ref-type="bibr">1</xref>). The transfer
of a frozen embryo enhances the cumulative pregnancy
rate, decreases cost, Is easy to perform
and can be fulfilled successfully in a relatively
shorter time span in comparison with repeated
fresh cycles (<xref rid="B2" ref-type="bibr">2</xref>-<xref rid="B5" ref-type="bibr">5</xref>). Furthermore, endometrial
receptivity can be compromised by controlled
ovarian hyperstimulation (COH) protocols (<xref rid="B6" ref-type="bibr">6</xref>)
and secretory endometrial transformation (<xref rid="B7" ref-type="bibr">7</xref>).
Endometrial development in frozen-thawed cycles
can be controlled more than during COH
cycles (<xref rid="B8" ref-type="bibr">8</xref>).</p><p>Various protocols (gonadotropin/GnRH agonists,
clomiphene citrate, or exogenous estrogen
and progesterone) have been discussed in literature
reviews with regards to the endometrium
preparation for frozen-thawed embryo transfer (<xref rid="B3" ref-type="bibr">3</xref>,
<xref rid="B9" ref-type="bibr">9</xref>). The most prevalent protocol for frozen-thawed
embryo transfer is the natural cycle or endometrial preparation with exogenous estrogen and progesterone,
with or without the addition of a GnRH
agonist (<xref rid="B10" ref-type="bibr">10</xref>-<xref rid="B12" ref-type="bibr">12</xref>).</p><p>Because the natural cycle protocol does not require
exogenous hormones&#x0201a; it is favored by many
patients (<xref rid="B13" ref-type="bibr">13</xref>). It has been observed that temporal
characteristics of the endometrium such as the
formation of pinopodes (markers of endometrial
receptivity) are out-of-phase according to measurements
in normal females who have been placed
on exogenous steroids (<xref rid="B14" ref-type="bibr">14</xref>). Thus, the transfer of
frozen-thawed embryos in natural cycles is a favored
option for women with normal ovulatory
menstrual cycles (<xref rid="B15" ref-type="bibr">15</xref>).</p><p>There is an idea that the endogenous production
of progesterone is enough to support
implantation in a natural cycle. However, an
inadequate progesterone level at the time of
implantation or during early pregnancy may
happen naturally due to luteal phase deficiency
(LPD), which can result in infertility or abortion
(<xref rid="B16" ref-type="bibr">16</xref>).</p><p>The reported frequency of LPD ranges from
3.7% to 20% among infertile patients (<xref rid="B17" ref-type="bibr">17</xref>, <xref rid="B18" ref-type="bibr">18</xref>).
The frequency has been demonstrated to be approximately
8.1% in natural cycles in normoovulatory
patients with primary or secondary
infertility (<xref rid="B19" ref-type="bibr">19</xref>). Thus, women who undergo frozen-
thawed embryo transfers may have sub optimal
endometrium during their natural cycles.
There is limited information about the effect
of luteal phase supplementation on pregnancy
rate in natural frozen-thawed embryo transfer
cycles. Therefore, we have designed a prospective
randomized study to verify if pregnancy
rates could be enhanced with progesterone supplementation
during the luteal phase and early
pregnancy following a frozen-thawed embryo
transfer in a natural cycle.</p></sec><sec sec-type="materials|methods"><title>Materials and Methods</title><sec><title>Study design</title><p>
The study was designed as a prospective randomized
clinical trial. A total of 102 women
each underwent an embryo transfer in a natural
cycle in Yazd Research and Clinical Center for
Infertility affiliated by Shahid Sadoughi University
of Medical Sciences, from March 2011
to March 2012. This study was approved by the
Ethics Committee of Yazd Research and Clinical
Center for Infertility. Prior to starting the
study&#x0201a; an informed consent was signed by each
couple. The inclusion criteria were: cryop reserved
embryos after conventional <italic>in vitro</italic> fertilization
(IVF) or intracytoplasmic sperm injection
(ICSI)&#x0201a; maternal age of 20-40 years (on
the day of embryo freezing)&#x0201a; regular menstrual
cycle of 25-35 days, and body mass index of
20-27 kg/m<sup>2</sup>. Exclusion criteria were: the use
of testicular sperm for ICSI (ejaculated sperm
only)&#x0201a; basal follicle stimulating hormone (FSH)
levels &#x02265;12 IU/l, stage III-IV endometriosis, and
polycystic ovarian syndrome (PCOS).</p></sec><sec><title>Randomization</title><p>
Patients were randomized to either group in
a ratio of 1:1 by means of computer-generated
random numbers on the day of participation.
Group selection and randomization were performed
by a nurse not involved in the study, by
using opaque sealed envelopes. Both the patients
and the clinicians were aware of the allocated
arm.</p></sec><sec><title>Treatment protocol</title><p>
Of the initial 109 women invited to participate,
102 were included in the study. All women
had previously undergone IVF or ICSI with
embryo cryopreservation. They were randomly
allocated to either the progesterone (n=51) or
the no-progesterone (n=51) groups. In the progesterone
group, we excluded four women. One
patient had an endometrial polyp and three patients
had thin endometria. Similarly, three patients
were excluded from the no-progesterone
group because of endometrial polyps (<xref rid="B2" ref-type="bibr">2</xref>) and
one patient who did not return to the study.
Thus, in this study, 102 women each underwent
an embryo transfer in a natural cycle. The final
analysis was performed on 51 patients in each
group. On the second or third days of the menstrual
cycle, all patients underwent transvaginal
ultrasounds and serum hormone analysis
for FSH. Then, a vaginal ultrasonographic examination
was performed on cycle days 10 and repeated as necessary. Final oocyte maturation
was achieved by intramuscular (IM) administration
of 10000 IU of hCG (Pregnyl, Daropakhsh,
Iran) when an endometrial thickness of 8
mm or more and a follicle of 18 mm were present
on the ultrasound. On the day of the hCG
administration, we measured serum estradiol&#x0201a;
progesterone and LH levels.</p><p>The progesterone group received 100mg/day
of progesterone (Aburaihan Pharmaceutical
Co., Tehran, Iran) IM, that began 36 hours after
the hCG administration and continued until
ten weeks of gestation if pregnancy occurred.
Control patients received no progesterone. In
both groups, cryopreserved embryo transfer
was performed with a Cook catheter (Cook Ireland
Ltd.) five days after hCG administration.
Serum &#x003b2;-hCG level was measured 14 days after
the transfer.</p></sec><sec><title>Embryo freezing-thawing</title><p>
Morphology of fresh cleavage-stage embryos
was evaluated according to the number of blastomeres
and degree of fragmentation. Embryo
selection for transfer or freezing was performed
in the morning of the transfer day. Embryos
were considered suitable for freezing if they
had &#x0003c;30% fragmentation. Cryopreservation of
all embryos was undertaken with vitrification
by the cryotop method on day 3 of pre implantation
development in both groups. After two-step
loading with equilibration solution that contained
ethylene glycol and dimethyl sulfoxide
and a vitrification solution that contained ethylene
glycol, dimethyl sulfoxide and sucrose,
a narrow glass capillary was used to load the
embryos onto the cryotop. After loading, the
majority of the solution was removed to leave
only a thin layer that covered the embryos, after
which the sample was quickly immersed into
liquid nitrogen. Subsequently, the plastic cap
was pulled over the film part of the cryotop and
the sample stored in liquid nitrogen. At warming,
the protective cap was removed from the
cryotop while it was still submerged in liquid
nitrogen and the cryotop was immersed directly
into a 37&#x002da;C medium that contained sucrose.
Next, the embryos were sequentially incubated
in diluent solution before further <italic>in vitro</italic> culture
for transfer. Each embryo was carefully evaluated
immediately after thawing for the number
of surviving blastomeres, followed by a second
evaluation the next morning. Embryos were accepted
for transfer if they retained &#x02265;50% of intact
blastomeres after thawing.</p></sec><sec><title>Outcome measures</title><p>
The main outcome measures concerned clinical
pregnancy and implantation rates. Chemical
pregnancy was defined as serum &#x003b2;-hCG&#x0003e;50
IU/L at 14 days after the embryo transfer. Clinical
pregnancy was defined as the presence of
a gestational sac with heart beat identified by
ultrasound 4-5 weeks after the embryo transfer.
Implantation rate was defined as the ratio of
gestational sacs to the number of embryos transferred.
Clinical abortion rate was determined as
clinically recognized pregnancy losses before
20 weeks of gestation.</p></sec><sec><title>Statistical analysis</title><p>
The SPSS 19 package program was used to
perform all statistical analyses. The normality of
distribution of variables was tested by the Kolmogorov-
Smirnov test. Independent sample t test
was used for continuous variables which were
normally distributed and Mann-Whitney U test for
data not normally distributed. Chi-square or Fisher
exact tests were used for qualitative variables as
appropriate. A p value &#x0003c;0.05 was considered statistically
significant. The data are presented as the
mean &#x000b1; standard deviation unless otherwise indicated.</p></sec></sec><sec sec-type="results"><title>Results</title><p>There were no significant differences noted in the fertilization rate between study and control
groups (55.4% vs. 64.3%; p=0.16). Of the 102 patients
included in this study, 51 received progesterone
and the other 51 did not. Table 1 describes
the basic characteristics of the patients in the two
groups. The demographic parameters were similar
in both groups in terms of age, basal FSH levels&#x0201a;
body mass index (BMI)&#x0201a; the number of previous
cycles&#x0201a; etiology of infertility, and infertility duration.
Table 2 compares the previous fresh cycle
characteristics in the two groups.</p><p>The mean number of oocytes retrieved&#x0201a; mean
number of mature oocytes and the number of embryos
obtained and vitrified did not differ between
the groups. There were no significant differences
noted in the fertilization rate (55.4% vs. 64.3%;
p=0.16). In addition, the previous stimulation protocols
and fertilization procedures were similar in
the two groups. Only ejaculated sperms had used
for conventional IVF or intracytoplasmic sperm
injection and percent of sperms with progressive
motility and sperms with normal morphology&#x0201a; also
sperm count were not different in those groups.
There was no significant difference observed
between the groups regarding the reasons for
embryo freezing. Table 3 compares the cycle
characteristics of the two groups. Endometrial
thickness and estradiol&#x0201a; progesterone and LH
levels on the day of hCG administration were
similar between groups.</p><p>The cycle length until the day of hCG administration&#x0201a;
number of embryos transferred, and the
number of good-quality embryos did not differ
in the two groups. Table 4 presents a comparison
of the pregnancy outcomes of the study groups.
Again, no statistically significant differences were
observed in the clinical pregnancy rate between
the groups (33.3% vs.27.5%, p=0.66). Although
there was a trend toward an increased clinical
pregnancy rate with luteal supplementation&#x0201a; the
difference was not significant. There were no differences
between the implantation rates (16.6% vs.
15.3%&#x0201a; p=0.93) or clinical abortion rates (11.8%
vs.14.3%&#x0201a; p=0.83). The flowchart of the study is
shown in figure 1.</p><table-wrap id="T1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Characteristics of patients</p></caption><table frame="hsides" rules="groups"><tbody><tr><th colspan="4" rowspan="1"><hr/></th></tr><tr><th rowspan="1" colspan="1">Outcome variable</th><th rowspan="1" colspan="1">Progesterone N=51</th><th rowspan="1" colspan="1">No progesterone N=51</th><th rowspan="1" colspan="1">P value</th></tr><tr><th colspan="4" rowspan="1"><hr/></th></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Age (Years)</bold></td><td rowspan="1" colspan="1">29.0 &#x000b1; 3.8</td><td rowspan="1" colspan="1">28.7 &#x000b1; 4.6</td><td rowspan="1" colspan="1">0.71</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>BMI (kg/m<sup>2</sup>)</bold></td><td rowspan="1" colspan="1">23.8 &#x000b1; 2.8</td><td rowspan="1" colspan="1">24.3 &#x000b1; 2.4</td><td rowspan="1" colspan="1">0.35</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Duration of infertility (Years)</bold></td><td rowspan="1" colspan="1">6.0 &#x000b1; 3.8</td><td rowspan="1" colspan="1">6.7 &#x000b1; 4.5</td><td rowspan="1" colspan="1">0.71</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Basal FSH (IU/L)</bold></td><td rowspan="1" colspan="1">5.8 &#x000b1; 1.9 </td><td rowspan="1" colspan="1">6.0 &#x000b1; 2.0</td><td rowspan="1" colspan="1">0.90</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Previous ART attempts n (%)</bold></td><td rowspan="1" colspan="1">14 (27.5)</td><td rowspan="1" colspan="1">17 (33.3)</td><td rowspan="1" colspan="1">0.51</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Etiology of infertility n (%)</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.62</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Male factor </bold></td><td rowspan="1" colspan="1">35 (68.6)</td><td rowspan="1" colspan="1">32 (62.7)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Tubal factor </bold></td><td rowspan="1" colspan="1">7 (13.8) </td><td rowspan="1" colspan="1">6 (11.8)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Unexplained</bold></td><td rowspan="1" colspan="1">9 (17.6)</td><td rowspan="1" colspan="1">13 (25.5)</td><td rowspan="1" colspan="1"/></tr><tr><th colspan="4" rowspan="1"><hr/></th></tr></tbody></table></table-wrap><table-wrap id="T2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Patients&#x02019; previous fresh cycle characteristics</p></caption><table frame="hsides" rules="groups"><tbody><tr><th colspan="4" rowspan="1"><hr/></th></tr><tr><th rowspan="1" colspan="1">Outcome variable</th><th rowspan="1" colspan="1">Progesterone N=51</th><th rowspan="1" colspan="1">No progesterone N=51</th><th rowspan="1" colspan="1">P value</th></tr><tr><th colspan="4" rowspan="1"><hr/></th></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Type of previous stimulation n (%) </bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.84</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Agonist protocol</bold></td><td rowspan="1" colspan="1">29 (56.9)</td><td rowspan="1" colspan="1">31(60.8)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Antagonist protocol</bold></td><td rowspan="1" colspan="1">22 (43.1)</td><td rowspan="1" colspan="1">20 (39.2)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" colspan="4" rowspan="1"><bold>Fertilization procedure n (%)</bold></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>IVF</bold></td><td rowspan="1" colspan="1">11 (21.6)</td><td rowspan="1" colspan="1">19 (37.3)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>ICSI</bold></td><td rowspan="1" colspan="1">40 (78.4)</td><td rowspan="1" colspan="1">32 (62.7)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>No. of oocytes retrieved</bold></td><td rowspan="1" colspan="1">10.0 &#x000b1; 4.3</td><td rowspan="1" colspan="1">9.6 &#x000b1; 3.4</td><td rowspan="1" colspan="1">0.16</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>No. of mature oocytes</bold></td><td rowspan="1" colspan="1">8.3 &#x000b1; 3.4</td><td rowspan="1" colspan="1">7.6 &#x000b1; 2.8</td><td rowspan="1" colspan="1">0.22</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>No. of embryos obtained</bold></td><td rowspan="1" colspan="1">6.2 &#x000b1; 1.6</td><td rowspan="1" colspan="1">5.7 &#x000b1; 2.2</td><td rowspan="1" colspan="1">0.19</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>No. of embryos vitrified</bold></td><td rowspan="1" colspan="1">4.3 &#x000b1; 1.0</td><td rowspan="1" colspan="1">4.0 &#x000b1; 0.6</td><td rowspan="1" colspan="1"> 0.07</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Fertilization rate (%)</bold></td><td rowspan="1" colspan="1">55.4</td><td rowspan="1" colspan="1">64.3</td><td rowspan="1" colspan="1">0.16</td></tr><tr><td align="left" colspan="4" rowspan="1"><bold>Sperm parameters</bold></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Count (mill/ml)</bold></td><td rowspan="1" colspan="1">12.6 &#x000b1; 7.7</td><td rowspan="1" colspan="1">11.9 &#x000b1; 7.0</td><td rowspan="1" colspan="1">0.62</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Progressive motility (%)</bold></td><td rowspan="1" colspan="1">15.0 &#x000b1; 5.8</td><td rowspan="1" colspan="1">14.5 &#x000b1; 6.9</td><td rowspan="1" colspan="1">0.72</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Normal morphology (%)</bold></td><td rowspan="1" colspan="1">15.3 &#x000b1; 9.8</td><td rowspan="1" colspan="1">14.2 &#x000b1; 7.3</td><td rowspan="1" colspan="1">0.51</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Cause of embryo freezing n (%) </bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.59</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Surplus embryos</bold></td><td rowspan="1" colspan="1">30 (58.8) </td><td rowspan="1" colspan="1">26 (45.1)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Risk of OHSS </bold></td><td rowspan="1" colspan="1">19 (37.3) </td><td rowspan="1" colspan="1">21(41.2)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Endometrial polyp</bold></td><td rowspan="1" colspan="1">2 (3.9)</td><td rowspan="1" colspan="1">4 (7.8)</td><td rowspan="1" colspan="1"/></tr><tr><th colspan="4" rowspan="1"><hr/></th></tr></tbody></table></table-wrap><table-wrap id="T3" orientation="portrait" position="float"><label>Table 3</label><caption><p>Frozen-thawed embryo replacement cycle characteristics</p></caption><table frame="hsides" rules="groups"><tbody><tr><th colspan="4" rowspan="1"><hr/></th></tr><tr><th rowspan="1" colspan="1">Outcome variable</th><th rowspan="1" colspan="1">Progesterone N=51</th><th rowspan="1" colspan="1">No progesterone N=51</th><th rowspan="1" colspan="1">P value</th></tr><tr><th colspan="4" rowspan="1"><hr/></th></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Endometrial thickness (mm)</bold></td><td rowspan="1" colspan="1">8.7 &#x000b1; 1.3</td><td rowspan="1" colspan="1">8.9 &#x000b1; 1.4</td><td rowspan="1" colspan="1">0.64</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>E2 on hCG day (pg/ml)</bold></td><td rowspan="1" colspan="1">208.4 &#x000b1; 60.2 median: 200</td><td rowspan="1" colspan="1">196.9 &#x000b1; 85.3 median: 170</td><td rowspan="1" colspan="1">0.11</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Progesterone on hCG day (ng/ml)</bold></td><td rowspan="1" colspan="1">0.77 &#x000b1; 0.09</td><td rowspan="1" colspan="1">0.80 &#x000b1; 0.07</td><td rowspan="1" colspan="1">0.08</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>LH on hCG day (IU/L)</bold></td><td rowspan="1" colspan="1">4.9 &#x000b1; 1.9</td><td rowspan="1" colspan="1">4.6 &#x000b1; 1.7</td><td rowspan="1" colspan="1">0.39</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold> No. of days until hCG</bold></td><td rowspan="1" colspan="1">14.3 &#x000b1; 1.8</td><td rowspan="1" colspan="1">13.7 &#x000b1; 1.5</td><td rowspan="1" colspan="1">0.07</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>No. of embryos transferred</bold></td><td rowspan="1" colspan="1">1.7 &#x000b1; 0.5
median: 2</td><td rowspan="1" colspan="1">1.9 &#x000b1; 0.5
median: 2</td><td rowspan="1" colspan="1">0.07</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Transfers with good quality embryos (%)</bold></td><td rowspan="1" colspan="1">54.9</td><td rowspan="1" colspan="1">60.8</td><td rowspan="1" colspan="1">0.54</td></tr><tr><th colspan="4" rowspan="1"><hr/></th></tr></tbody></table></table-wrap><table-wrap id="T4" orientation="portrait" position="float"><label>Table 4</label><caption><p>Pregnancy outcomes</p></caption><table frame="hsides" rules="groups"><tbody><tr><th colspan="4" rowspan="1"><hr/></th></tr><tr><th rowspan="1" colspan="1">Outcome variable</th><th rowspan="1" colspan="1">Progesterone N=51</th><th rowspan="1" colspan="1">No progesterone N=51</th><th rowspan="1" colspan="1">P value</th></tr><tr><th colspan="4" rowspan="1"><hr/></th></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Chemical pregnancy rate&#x0201a; n (%)</bold></td><td rowspan="1" colspan="1">18 (35.3)</td><td rowspan="1" colspan="1">16 (31.4)</td><td rowspan="1" colspan="1">0.83</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Clinical pregnancy rate&#x0201a; n (%)</bold></td><td rowspan="1" colspan="1">17 (33.3)</td><td rowspan="1" colspan="1">14 (27.5)</td><td rowspan="1" colspan="1"> 0.66</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Implantation rate (%)</bold></td><td rowspan="1" colspan="1"> 16.6</td><td rowspan="1" colspan="1">15.3</td><td rowspan="1" colspan="1">0.93</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Clinical abortion rate&#x0201a; n (%)</bold></td><td rowspan="1" colspan="1">2 (11.8)</td><td rowspan="1" colspan="1">2 (14.3)</td><td rowspan="1" colspan="1">0.83</td></tr><tr><th colspan="4" rowspan="1"><hr/></th></tr></tbody></table></table-wrap><fig id="F1" orientation="portrait" position="float"><label>Fig 1</label><caption><p>Flowchart of study patients</p></caption><graphic xlink:href="Int-J-Fertil-Steril-7-13-g01"/></fig></sec><sec sec-type="discussion"><title>Discussion</title><p>The granulosa cells of the developing follicle generate
estradiol in response to gonadotropin stimulation
in natural cycles. The endometrium acquires
receptivity to embryo implantation by responding
to progesterone action on an appropriately primed
endometrium. Estrogenic stimulation would result in
endometrial proliferation and the induction of progesterone
receptors. The endometrium undertakes
profound conformational and biochemical changes,
from proliferative to secretory, with a concomitant
induction of endometrial receptivity and opening of
the window of implantation in response to progesterone
(<xref rid="B20" ref-type="bibr">20</xref>). During the implantation window, the endometrium
which is unexpectedly unreceptive towards
embryo implantation acquires a functional condition
useful to blastocyst reception (<xref rid="B21" ref-type="bibr">21</xref>).</p><p>The transfer of frozen-thawed embryos has important
implications for the management of women undergoing
ovarian hyperstimulation for IVF (<xref rid="B2" ref-type="bibr">2</xref>). Frozen embryo
transfer is reported to be successful during the natural
cycle after spontaneous ovulation according to the literature
(<xref rid="B22" ref-type="bibr">22</xref>). In a study by Morozov et al. a higher pregnancy
rate was observed in recipients who underwent
natural cryothaw cycles than in hormone replacement
treatment cycles. In their study the level of estradiol was
greater in the substitution cycles when compared with
the natural cycle. Regarding those results, we have supported
the theory that the window of uterine receptivity
closes earlier at a higher endogenous estrogen level and
limits the time for the transferred embryos to implant
successfully (<xref rid="B9" ref-type="bibr">9</xref>). According to their results,hormone
replacement treatment versus the natural cycle for cryothaw
embryo transfer was associated with decreased
pregnancy rates. In the current study, we have evaluated
the outcome of hCG-induced natural cryothawed
embryo transfer cycles that were supported during the
luteal phase with IM progesterone. We compared this
with the outcome of hCG-induced natural cycles in the
absence of luteal phase support.</p><p>Our hypothesis was that progesterone support has a
beneficial effect on pregnancy rate after frozen embryo
transfer in natural cycles, but the results did not support
our hypothesis. In our study, hCG was used for final oocyte
maturation. It was suggested that hCG administered
for the final oocyte maturation in stimulated IVF cycles
would cause a luteal phase defect by suppressing LH
production through a short-loop feedback mechanism
(<xref rid="B23" ref-type="bibr">23</xref>) although the use of hCG did not down-regulate LH
secretion in the luteal phase of regular and unstimulated
cycles in women with normal ovulation (<xref rid="B24" ref-type="bibr">24</xref>). Additionally,
in our study none of the patients developed premature
luteinization. Premature LH surge is defined as
an LH level of &#x02265;10 IU/L and a progesterone level of
&#x02265;1.0 ng/ml on the day of hCG administration (<xref rid="B25" ref-type="bibr">25</xref>). An
elevated progesterone level advances the endometrium&#x0201a;
therefore the replacement of day 3 embryos occur in an
asynchronous endometrium with subsequent failure of
establishing an embryo-endometrium cross-dialog, resulting
in implantation failure (<xref rid="B26" ref-type="bibr">26</xref>).</p><p>Bourgain et al. have reported that progesterone induces
a secretory transformation of the endometrium in
the luteal phase (<xref rid="B27" ref-type="bibr">27</xref>) and by inducing this change after
sufficient estrogen priming, progesterone improves
endometrial receptivity (<xref rid="B28" ref-type="bibr">28</xref>). Progesterone not only
supports endometrial development but also maintains
embryo survival by shifting the immune system toward
the production of non-inflammatory Th2 cytokines (<xref rid="B29" ref-type="bibr">29</xref>,
<xref rid="B30" ref-type="bibr">30</xref>). In addition, by inducing nitric oxide synthesis in the
deciduas&#x0201a; they intensify local vasodilatation and uterine
repose (<xref rid="B31" ref-type="bibr">31</xref>). A study by Orvieto et al. has shown that,
in artificial cryothawed embryo transfer cycles, a highdose
progesterone supplementation in the luteal phase
resulted in a higher clinical pregnancy rate (<xref rid="B32" ref-type="bibr">32</xref>).</p><p>In contrast to our study, Bjuresten et al. have reported
that progesterone supplementation improved the live
birth rate after embryo transfer in natural cycles (<xref rid="B15" ref-type="bibr">15</xref>). In
their study, women received vaginal progesterone at a
dose of 400 mg twice a day from the day of the embryo
transfer. They attributed the increase in live birth rate
to the effects of vaginal progesterone. Vaginal progesterone
results in adequate endometrial development, in
spite of low serum progesterone levels.</p><p>Our study was in agreement with a study by Kyrou et
al. that reported luteal phase support did not affect ongoing
pregnancy rates in natural hCG-induced frozenthawed
embryo transfer cycles (<xref rid="B33" ref-type="bibr">33</xref>). A possible reason
for our finding was that the women in the present study
had a normal ovulatory function; those with ovulatory
dysfunction were excluded from the study. Luteal phase
defect in stimulated IVF cycles is due to supra physiological
levels of steroids which directly inhibit the LH
release via negative feedback actions at the hypothalamic-
pituitary axis level (<xref rid="B34" ref-type="bibr">34</xref>). However it seems that LPD
is not a main etiologic factor for implantation failure in
natural frozen thawed embryo transfer cycles.</p></sec><sec sec-type="conclusions"><title>Conclusion</title><p>There emerged no significant differences between the two groups in our study with regards to the implantation
or clinical pregnancy rates&#x0201a; but there was
a trend toward an increased clinical pregnancy rate
with luteal supplementation. Thus, further studies are
needed to confirm our findings.</p></sec></body><back><ack><p>We would like to express our gratitude to the
Yazd Research and Clinical Center for Infertility
for their great insights and invaluable assistance in
this research project. This study was supported by
Shahid Sadoughi University of Medical Sciences.
There is no conflict of interest in this article.</p></ack><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trounson</surname><given-names>A</given-names></name><name><surname>Mohr</surname><given-names>L</given-names></name></person-group><article-title>Human pregnancy following cryopreservation,
thawing and transfer of an eight-cell embryo</article-title><source>Nature</source><year>1983</year><volume>305</volume><issue>5936</issue><fpage>707</fpage><lpage>709</lpage><pub-id pub-id-type="pmid">6633637</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gelbaya</surname><given-names>TA</given-names></name><name><surname>Nardo</surname><given-names>LG</given-names></name><name><surname>Hunter</surname><given-names>HR</given-names></name><name><surname>Fitzgerald</surname><given-names>CT</given-names></name><name><surname>Horne</surname><given-names>G</given-names></name><name><surname>Pease</surname><given-names>EE</given-names></name><etal/></person-group><article-title>Cryopreserved-thawed embryo transfer in
natural or down-regulated hormonally controlled cycles: a retrospective
study</article-title><source>Fertil Steril</source><year>2006</year><volume>85</volume><issue>3</issue><fpage>603</fpage><lpage>609</lpage><pub-id pub-id-type="pmid">16500326</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghobara</surname><given-names>T</given-names></name><name><surname>Vandekerckhove</surname><given-names>P</given-names></name></person-group><article-title>Cycle regimens for frozenthawed
embryo transfer</article-title><source>Cochrane Database Syst Rev</source><year>2008</year><issue>1</issue><fpage>CD003414</fpage><lpage>CD003414</lpage><pub-id pub-id-type="pmid">18254019</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lahav-Baratz</surname><given-names>S</given-names></name><name><surname>Koifman</surname><given-names>M</given-names></name><name><surname>Shiloh</surname><given-names>H</given-names></name><name><surname>Ishai</surname><given-names>D</given-names></name><name><surname>Wiener-Megnazi</surname><given-names>Z</given-names></name><name><surname>Dirnfeld</surname><given-names>M</given-names></name></person-group><article-title>Analyzing factors affecting the success rate of
frozen&#x02013;thawed embryos</article-title><source>J Assist Reprod Genet</source><year>2003</year><volume>20</volume><issue>11</issue><fpage>444</fpage><lpage>448</lpage><pub-id pub-id-type="pmid">14714822</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Urman</surname><given-names>B</given-names></name><name><surname>Balaban</surname><given-names>B</given-names></name><name><surname>Yakin</surname><given-names>K</given-names></name></person-group><article-title>Impact of fresh-cycle variables on
the implantation potential of cryopreserved-thawed human embryos</article-title><source>Fertil Steril</source><year>2007</year><volume>87</volume><issue>2</issue><fpage>310</fpage><lpage>315</lpage><pub-id pub-id-type="pmid">17097088</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haouzi</surname><given-names>D</given-names></name><name><surname>Assou</surname><given-names>S</given-names></name><name><surname>Mahmoud</surname><given-names>K</given-names></name><name><surname>Tondeur</surname><given-names>S</given-names></name><name><surname>R&#x000e8;me</surname><given-names>T</given-names></name><name><surname>Hedon</surname><given-names>B</given-names></name><etal/></person-group><article-title>Gene expression profile of human endometrial receptivity:
comparison between natural and stimulated cycles for the same
patients</article-title><source>Hum Reprod</source><year>2009</year><volume>24</volume><issue>9</issue><fpage>1436</fpage><lpage>1445</lpage><pub-id pub-id-type="pmid">19246470</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Devroey</surname><given-names>P</given-names></name><name><surname>Bourgain</surname><given-names>C</given-names></name><name><surname>Macklon</surname><given-names>NS</given-names></name><name><surname>Fauser</surname><given-names>BC</given-names></name></person-group><article-title>Reproductive
biology and IVF: ovarian stimulation and endometrial receptivity</article-title><source>Trends Endocrinol Metab</source><year>2004</year><volume>15</volume><issue>2</issue><fpage>84</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">15036255</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shapiro</surname><given-names>BS</given-names></name><name><surname>Daneshmand</surname><given-names>ST</given-names></name><name><surname>Garner</surname><given-names>FC</given-names></name><name><surname>Aguirre</surname><given-names>M</given-names></name><name><surname>Ross</surname><given-names>R</given-names></name></person-group><article-title>Contrasting patterns in in vitro fertilization pregnancy rates among
fresh autologous, fresh oocyte donor, and cryopreserved cycles
with the use of day 5 or day 6 blastocysts may reflect differences
in embryo-endometrium synchrony</article-title><source>Fertil Steril</source><year>2008</year><volume>89</volume><issue>1</issue><fpage>20</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">17224151</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morozov</surname><given-names>V</given-names></name><name><surname>Ruman</surname><given-names>J</given-names></name><name><surname>Kenigsberg</surname><given-names>D</given-names></name><name><surname>Moodie</surname><given-names>G</given-names></name><name><surname>Brenner</surname><given-names>S</given-names></name></person-group><article-title>Natural cycle cryo-thaw transfer may improve pregnancy outcome</article-title><source>J Assist Reprod Genet</source><year>2007</year><volume>24</volume><issue>4</issue><fpage>119</fpage><lpage>123</lpage><pub-id pub-id-type="pmid">17450431</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawamura</surname><given-names>T</given-names></name><name><surname>Motoyama</surname><given-names>H</given-names></name><name><surname>Yanaihara</surname><given-names>A</given-names></name><name><surname>Yorimitsu</surname><given-names>T</given-names></name><name><surname>Arichi</surname><given-names>A</given-names></name><name><surname>Karasawa</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Clinical outcomes of two different endometrial
preparation methods for cryopreserved-thawed embryo transfer
in patients with a normal menstrual cycle</article-title><source>Reprod Med Biol</source><year>2007</year><volume>6</volume><issue>1</issue><fpage>53</fpage><lpage>57</lpage></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oehninger</surname><given-names>S</given-names></name><name><surname>Mayer</surname><given-names>J</given-names></name><name><surname>Muasher</surname><given-names>S</given-names></name></person-group><article-title>Impact of different clinical variables
on pregnancy outcome following embryo cryopreservation</article-title><source>Mol Cell Endocrinol</source><year>2000</year><volume>169</volume><issue>1-2</issue><fpage>73</fpage><lpage>77</lpage><pub-id pub-id-type="pmid">11155958</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>CL</given-names></name><name><surname>De Ziegler</surname><given-names>D</given-names></name><name><surname>Gagliardi</surname><given-names>CL</given-names></name><name><surname>Mellon</surname><given-names>RW</given-names></name><name><surname>Taney</surname><given-names>F</given-names></name><name><surname>Kuhar</surname><given-names>M</given-names></name><etal/></person-group><article-title>Transfer of cryopreserved-thawed embryos: the natural
cycle versus controlled preparation of the endometrium with
gonadotropin-releasing hormone agonist and exogenous estradiol
and progesterone (GEEP)</article-title><source>Fertil Steril</source><year>1989</year><volume>52</volume><issue>4</issue><fpage>609</fpage><lpage>616</lpage><pub-id pub-id-type="pmid">2680619</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dal Prato</surname><given-names>L</given-names></name><name><surname>Borini</surname><given-names>A</given-names></name><name><surname>Cattoli</surname><given-names>M</given-names></name><name><surname>Bonu</surname><given-names>MA</given-names></name><name><surname>Sciajno</surname><given-names>R</given-names></name><name><surname>Flamigni</surname><given-names>C</given-names></name></person-group><article-title>Endometrial preparation for frozen-thawed embryo transfer with
or without pretreatment with gonadotropin-releasing hormone
agonist</article-title><source>Fertil Steril</source><year>2002</year><volume>77</volume><issue>5</issue><fpage>956</fpage><lpage>960</lpage><pub-id pub-id-type="pmid">12009350</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>SM</given-names></name><name><surname>Terry</surname><given-names>V</given-names></name><name><surname>Hosie</surname><given-names>MJ</given-names></name><name><surname>Gayer</surname><given-names>N</given-names></name><name><surname>Murphy</surname><given-names>CR</given-names></name></person-group><article-title>Endometrial
response to IVF hormonal manipulation: Comparative analysis of
menopausal, down regulated and natural cycles</article-title><source>Reprod Biol Endocrinol</source><year>2004</year><volume>2</volume><fpage>21</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">15117407</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bjuresten</surname><given-names>K</given-names></name><name><surname>Landgren</surname><given-names>BM</given-names></name><name><surname>Hovatta</surname><given-names>O</given-names></name><name><surname>Stavreus-Evers</surname><given-names>A</given-names></name></person-group><article-title>Luteal
phase progesterone increases live birth rate after frozen embryo
transfer</article-title><source>Fertil Steril</source><year>2011</year><volume>95</volume><issue>2</issue><fpage>534</fpage><lpage>537</lpage><pub-id pub-id-type="pmid">20579989</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daya</surname><given-names>S</given-names></name></person-group><article-title>Luteal support: progestogens for pregnancy protection</article-title><source>Maturitas</source><year>2009</year><volume>65</volume><issue>Suppl 1</issue><fpage>S29</fpage><lpage>S34</lpage><pub-id pub-id-type="pmid">19913373</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balasch</surname><given-names>J</given-names></name><name><surname>Vanrell</surname><given-names>JA</given-names></name></person-group><article-title>Luteal phase deficiency: an inadequate
endometrial response to normal hormone stimulation</article-title><source>Int J Fertil</source><year>1986</year><volume>31</volume><issue>5</issue><fpage>368</fpage><lpage>371</lpage><pub-id pub-id-type="pmid">2898441</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olive</surname><given-names>DL</given-names></name></person-group><article-title>The prevalence and epidemiology of luteal-phase deficiency
in normal and infertile women</article-title><source>Clin Obstet Gynecol</source><year>1991</year><volume>34</volume><issue>1</issue><fpage>157</fpage><lpage>166</lpage><pub-id pub-id-type="pmid">2025966</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenberg</surname><given-names>SM</given-names></name><name><surname>Luciano</surname><given-names>AA</given-names></name><name><surname>Riddick</surname><given-names>DH</given-names></name></person-group><article-title>The luteal phase defect:
the relative frequency of, and encouraging response to, treatment
with vaginal progesterone</article-title><source>Fertil Steril</source><year>1980</year><volume>34</volume><issue>1</issue><fpage>17</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">7398902</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kodaman</surname><given-names>PH</given-names></name><name><surname>Taylor</surname><given-names>HS</given-names></name></person-group><article-title>Hormonal regulation of implantation</article-title><source>Obstet Gynecol Clin North Am</source><year>2004</year><volume>31</volume><issue>4</issue><fpage>745</fpage><lpage>766</lpage><pub-id pub-id-type="pmid">15550333</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kabir-Salmani</surname><given-names>M</given-names></name><name><surname>Murphy</surname><given-names>CR</given-names></name><name><surname>Hosseini</surname><given-names>A</given-names></name><name><surname>Valojerdi</surname><given-names>MR</given-names></name></person-group><article-title>Ultrastructural
modifications of human endometrium during the window
of implantation</article-title><source>Int J Fertil Steril</source><year>2008</year><volume>2</volume><issue>2</issue><fpage>44</fpage><lpage>59</lpage></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Shawaf</surname><given-names>T</given-names></name><name><surname>Yang</surname><given-names>D</given-names></name><name><surname>Al-Magid</surname><given-names>Y</given-names></name><name><surname>Seaton</surname><given-names>A</given-names></name><name><surname>Iketubosin</surname><given-names>F</given-names></name><name><surname>Craft</surname><given-names>I</given-names></name></person-group><article-title>Infertility: Ultrasonic monitoring during replacement of frozen/
thawed embryos in natural and hormone replacement cycles</article-title><source>Hum Reprod</source><year>1993</year><volume>8</volume><issue>12</issue><fpage>2068</fpage><lpage>2074</lpage><pub-id pub-id-type="pmid">8150904</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyake</surname><given-names>A</given-names></name><name><surname>Aono</surname><given-names>T</given-names></name><name><surname>Kinugasa</surname><given-names>T</given-names></name><name><surname>Tanizawa</surname><given-names>O</given-names></name><name><surname>Kurachi</surname><given-names>K</given-names></name></person-group><article-title>Suppression
of serum levels of luteinizing hormone by short-and long-loop
negative feedback in ovariectomized women</article-title><source>J Endocrinol</source><year>1979</year><volume>80</volume><issue>3</issue><fpage>353</fpage><lpage>356</lpage><pub-id pub-id-type="pmid">220373</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tavaniotou</surname><given-names>A</given-names></name><name><surname>Devroey</surname><given-names>P</given-names></name></person-group><article-title>Effect of human chorionic gonadotropin
on luteal luteinizing hormone concentrations in natural cycles</article-title><source>Fertil Steril</source><year>2003</year><volume>80</volume><issue>3</issue><fpage>654</fpage><lpage>655</lpage><pub-id pub-id-type="pmid">12969719</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elnashar</surname><given-names>AM</given-names></name></person-group><article-title>Progesterone rise on the day of HCG administration
(premature luteinization) in IVF: An overdue update</article-title><source>J Assist
Reprod Genet</source><year>2010</year><volume>27</volume><issue>4</issue><fpage>149</fpage><lpage>155</lpage><pub-id pub-id-type="pmid">20177771</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papanikolaou</surname><given-names>EG</given-names></name><name><surname>Kolibianakis</surname><given-names>EM</given-names></name><name><surname>Pozzobon</surname><given-names>C</given-names></name><name><surname>Tank</surname><given-names>P</given-names></name><name><surname>Tournaye</surname><given-names>H</given-names></name><name><surname>Bourgain</surname><given-names>C</given-names></name><etal/></person-group><article-title>Progesterone rise on the day of human
chorionic gonadotropin administration impairs pregnancy
outcome in day 3 single-embryo transfer, while has no effect on
day 5 single blastocyst transfer</article-title><source>Fertil steri</source><year>2009</year><volume>91</volume><issue>3</issue><fpage>949</fpage><lpage>952</lpage></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bourgain</surname><given-names>C</given-names></name><name><surname>Devroey</surname><given-names>P</given-names></name><name><surname>Van Waeshberghe</surname><given-names>L</given-names></name><name><surname>Smitz</surname><given-names>J</given-names></name><name><surname>Van Steirteghem</surname><given-names>AC</given-names></name></person-group><article-title>Effects of natural progesterone on the morphology
of the endometrium in patients with primary ovarian failure</article-title><source>Hum Reprod</source><year>1990</year><volume>5</volume><issue>5</issue><fpage>537</fpage><lpage>543</lpage><pub-id pub-id-type="pmid">2394784</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kolibianakis</surname><given-names>EM</given-names></name><name><surname>Devroey</surname><given-names>P</given-names></name></person-group><article-title>The luteal phase after ovarian stimulation</article-title><source>Reprod Biomed Online</source><year>2002</year><volume>2</volume><issue>Suppl 1</issue><fpage>26</fpage><lpage>35</lpage><pub-id pub-id-type="pmid">12537779</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Druckmann</surname><given-names>R</given-names></name><name><surname>Druckmann</surname><given-names>MA</given-names></name></person-group><article-title>Progesterone and the immunology
of pregnancy</article-title><source>J Steroid Biochem Mol Biol</source><year>2005</year><volume>97</volume><issue>5</issue><fpage>389</fpage><lpage>396</lpage><pub-id pub-id-type="pmid">16198558</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szekeres-Bartho</surname><given-names>J</given-names></name><name><surname>Wilczynski</surname><given-names>JR</given-names></name><name><surname>Basta</surname><given-names>P</given-names></name><name><surname>Kalinka</surname><given-names>J</given-names></name></person-group><article-title>Role of
progesterone and progestin therapy in threatened abortion and
preterm labour</article-title><source>Front Biosci</source><year>2008</year><volume>13</volume><fpage>1981</fpage><lpage>1990</lpage><pub-id pub-id-type="pmid">17981685</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bulletti</surname><given-names>C</given-names></name><name><surname>De Ziegler</surname><given-names>D</given-names></name></person-group><article-title>Uterine contractility and embryo implantation</article-title><source>Curr Opin Obstet Gynecol</source><year>2005</year><volume>17</volume><issue>3</issue><fpage>265</fpage><lpage>276</lpage><pub-id pub-id-type="pmid">15870561</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orvieto</surname><given-names>R</given-names></name><name><surname>Meltcer</surname><given-names>S</given-names></name><name><surname>Volodarski</surname><given-names>M</given-names></name><name><surname>Scharf</surname><given-names>S</given-names></name><name><surname>Rabinson</surname><given-names>J</given-names></name><name><surname>Zohav</surname><given-names>E</given-names></name><etal/></person-group><article-title>Luteal phase support for patients undergoing frozenthawed
embryo transfer cycles--the required progesterone dose</article-title><source>Clin Exp Obstet Gynecol</source><year>2007</year><volume>34</volume><issue>1</issue><fpage>25</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">17447632</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kyrou</surname><given-names>D</given-names></name><name><surname>Fatemi</surname><given-names>HM</given-names></name><name><surname>Popovic-Todorovic</surname><given-names>B</given-names></name><name><surname>Van den Abbeel</surname><given-names>E</given-names></name><name><surname>Camus</surname><given-names>M</given-names></name><name><surname>Devroey</surname><given-names>P</given-names></name></person-group><article-title>Vaginal progesterone supplementation
has no effect on ongoing pregnancy rate in hCG-induced natural
frozen-thawed embryo transfer cycles</article-title><source>Eur J Obstet Gynecol Reprod Biol</source><year>2010</year><volume>150</volume><issue>2</issue><fpage>175</fpage><lpage>179</lpage><pub-id pub-id-type="pmid">20219279</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fauser</surname><given-names>BC</given-names></name><name><surname>Devroey</surname><given-names>P</given-names></name></person-group><article-title>Reproductive biology and IVF: ovarian
stimulation and luteal phase consequences</article-title><source>Trends Endocrinol Metab</source><year>2003</year><volume>14</volume><issue>5</issue><fpage>236</fpage><lpage>242</lpage><pub-id pub-id-type="pmid">12826330</pub-id></element-citation></ref></ref-list></back></article>